Mayne Pharma appoints former Organon & Co executive Meghan Rivera to board

The news: Mayne Pharma has appointed Meghan Rivera as a non-executive director, effective 26 June.

The context: Rivera brings over 25 years of experience in the US pharmaceuticals industry, having previously served as US market president at Organon & Co, chief marketing officer at Akili Interactive and senior vice president of women’s health at AMAG Pharmaceuticals.

She currently serves as vice president and global commercial lead for ViiV Healthcare.

What they said: “Having spent my career building high-performing US pharma organisations, I recognise the quality of what Mayne has assembled that has strong strategic merit and genuine competitive advantage,” Rivera said.